Radium-223

Radiochemicals

Description
Radium-223 dichloride is an alpha particle-emitting radiotherapy drug that mimics calcium and forms complexes with hydroxyapatite at areas of increased bone turnover. The principal use of radium-223, as a radiopharmaceutical to treat metastatic cancers in bone, takes advantage of its chemical similarity to calcium, and the short-range of the alpha radiation it emits.

Status
Inquire

Radionuclidic purity

Radiochemical purity
>—%

Chemical formula

Concentration

Specific activity

Half life
11.4 days

Calibration

Form

Regions
Africa, Asia, Australia, Canada, Europe, Latin America, Middle East, USA

Decay Calculator

Initial activity

mCi

Elapsed time

days


Final activity